Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
6.21M
-
Shares change
-
+3.24M
-
Total reported value, excl. options
-
$129M
-
Value change
-
+$67.9M
-
Number of buys
-
37
-
Number of sells
-
-7
-
Price
-
$20.78
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2018
48 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2018.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.21M shares
of 29.1M outstanding shares and own 21.36% of the company stock.
Largest 10 shareholders include FMR LLC (1.24M shares), FRAZIER MANAGEMENT LLC (875K shares), BAKER BROS. ADVISORS LP (785K shares), GREAT POINT PARTNERS LLC (492K shares), Vanguard Group Inc (337K shares), CITADEL ADVISORS LLC (335K shares), Redmile Group, LLC (325K shares), PRICE T ROWE ASSOCIATES INC /MD/ (304K shares), Knoll Capital Management, LP (300K shares), and Artal Group S.A. (275K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.